<DOC>
	<DOC>NCT00813995</DOC>
	<brief_summary>A study to assess the safety and efficacy of the addition of sitagliptin compared to placebo in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin.</brief_summary>
	<brief_title>A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>18 78 years of age Currently on metformin monotherapy History of Type 1 diabetes mellitus or ketoacidosis Currently on a weight loss program and not in the maintenance phase or has started on a weight loss medication within the last 8 weeks Has undergone surgery requiring general anesthesia within the past 4 weeks or has planned major surgery Currently participating in a study or has participated in a study with or without an investigational compound or device within the past 12 weeks History of active liver disease such as chronic active hepatitis B or C, cirrhosis or symptomatic gallbladder disease HIV positive Pregnant, breastfeeding or planning to become pregnant during the study User of recreational or illicit drugs or has a recent history (within the past year) of drug or alcohol abuse or dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>